Drug Recall: Mucus Relief D Subpotent Tablets
Dr. Reddy's Laboratories is recalling Mucus Relief D (Guaifenesin Pseudoephedrine HCl ER Tablets) nationwide due to subpotency. The affected product was distributed to Walgreen Co. stores across the USA.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: This is an FDA Class III recall for a subpotent drug with no reported illnesses or injuries. The source text does not indicate any patient harm or safety hazard—only that the drug contains less active ingredient than labeled. Per the rubric, Class III recalls are typically scored 1 or 2, and with no reported adverse events, a score of 1 applies.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Mucus Relief D, Guaifenesin Pseudoephedrine HCl ER Tablets, 600 mg/60 mg, due to subpotency (lower-than-specified potency).
The affected product is packaged in 36-count blister packs placed in cartons and was distributed by Walgreen Co. across the USA. The recall involves 18,336 cartons with lot numbers AT2102065A and AT2102065B, expiration date 04/2023. The drug was manufactured in India.
This is a voluntary recall initiated by the manufacturer. Consumers who have purchased this product should stop using it and return it to the point of purchase or contact Dr. Reddy's Laboratories, Inc. for additional information.
The recalled product
- Product
- Mucus Relief D, Guaifenesin Pseudoephedrine HCl ER Tablets, 600 mg/60mg, packaged in 36-count blister pack packed into cartons, Distributed by: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, Made in India, NDC 0363-164-3
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Hazard
- subpotency
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: AT2102065A
- AT2102065B
- Exp 04/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27